Perceptive Advisors LLC Vbi Vaccines Inc Transaction History

Perceptive Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $5.98 Million - $8.72 Million	-2,707,463 Reduced 4.92%	52,335,002 $122 Million
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $7.91 Million - $28.5 Million	9,090,909 Added 19.78%	55,042,465 $171 Million
Q3 2019 Nov 14, 2019	BUY	$0.47 - $1.05 $9.4 Million - $21 Million	20,000,000 Added 77.07%	45,951,556 $46 Million
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $1.3 Million - $4.24 Million	2,000,000 Added 8.35%	25,951,556 $24.6 Million
Q4 2018 Feb 14, 2019	BUY	$1.22 - $2.41 $17.4 Million - $34.4 Million	14,285,713 Added 147.8%	23,951,556 $38.3 Million
Q4 2017 Feb 14, 2018	BUY	$3.29 - $5.03 $10.2 Million - $15.6 Million	3,100,000 Added 47.21%	9,665,843 $41.3 Million
Q3 2017 Nov 14, 2017	BUY	$3.15 - $4.01 $20.7 Million - $26.3 Million	6,565,843	6,565,843 $25.3 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.